Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: a network meta-analysis

L Calzetta, F Di Marco, F Blasi, M Cazzola… - Pulmonary …, 2019 - Elsevier
Background Inhaled corticosteroid (ICS)/long-acting β 2 agonist (LABA) fixed-dose
combinations (FDCs) and LABA/long-acting muscarinic antagonist (LAMA) FDCs are …

Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis

L Calzetta, F Di Marco, F Blasi… - Pulmonary …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Inhaled corticosteroid (ICS)/long-acting β 2 agonist (LABA) fixed-dose
combinations (FDCs) and LABA/long-acting muscarinic antagonist (LAMA) FDCs are …

Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis.

L Calzetta, F Di Marco, F Blasi, M Cazzola… - Pulmonary …, 2019 - europepmc.org
BACKGROUND: Inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) fixed-dose
combinations (FDCs) and LABA/long-acting muscarinic antagonist (LAMA) FDCs are …

Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis

L Calzetta, F Di Marco, F Blasi, M Cazzola… - PULMONARY …, 2019 - air.unipr.it
Background: Inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) fixed-dose
combinations (FDCs) and LABA/long-acting muscarinic antagonist (LAMA) FDCs are …

Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis

L Calzetta, F Di Marco, F Blasi, M Cazzola… - PULMONARY …, 2019 - air.unimi.it
Background: Inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) fixed-dose
combinations (FDCs) and LABA/long-acting muscarinic antagonist (LAMA) FDCs are …

Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis

L Calzetta, F Di Marco, F Blasi, M Cazzola… - PULMONARY …, 2019 - art.torvergata.it
Abstract Inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) fixed-dose combinations
(FDCs) and LABA/long-acting muscarinic antagonist (LAMA) FDCs are extensively used to …